Legal Representation
Attorney
Neal Wolgin
USPTO Deadlines
Next Deadline
1805 days remaining
Section 8 & 9 Renewal Due (Principal Register) (20-Year) (Based on R.PRA event 2010-11-30)
Due Date
November 30, 2030
Grace Period Ends
May 30, 2031
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 2, 2021 | CAEX | O | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | Loading... |
| Nov 30, 2019 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | Loading... |
| Jan 25, 2017 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | Loading... |
| Jan 25, 2017 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | Loading... |
| Jan 25, 2017 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Nov 15, 2016 | E815 | I | TEAS SECTION 8 & 15 RECEIVED | Loading... |
| Nov 30, 2015 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| May 8, 2012 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Nov 30, 2010 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Sep 14, 2010 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 14, 2010 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 12, 2010 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Aug 12, 2010 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jul 27, 2010 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 27, 2010 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jul 27, 2010 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 27, 2010 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 27, 2010 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jul 20, 2010 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 19, 2010 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 16, 2010 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"CLINICAL TRIAL"